incretin mimetics glp 1 agonists Incretins: How we got here, where we're at and what is coming next Incretin - an overview |

In 2002, a 6-week subcutaneous infusion of GLP-1 showed a robust glucose-lowering effect in patients with type 2 diabetes [6]

Informed Consent Statement Not applicable

Table 2: Summary of anaesthetic-related recommendations and considerations for case management to reduce risks of aspiration

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm2018 executive summary

Trials using inulin, oligofructose, resistant starch and other prebiotics have reported shortterm rises in GLP1 and metaanalyses indicate modest metabolic benefits